Crescita Therapeutics Inc. (TSX:CTX)
Canada
· Delayed Price · Currency is CAD 0.750
0.00 (0.00%)
Apr 28, 2026, 1:49 PM EST
Crescita Therapeutics Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14 | 9 | 11 | 10 | 13 | 14 | Upgrade
|
| Market Cap Growth | 29.98% | -19.68% | 13.57% | -27.40% | -1.08% | -5.64% | Upgrade
|
| Enterprise Value | 6 | 1 | 4 | 1 | 4 | 4 | Upgrade
|
| Last Close Price | 0.75 | 0.48 | 0.58 | 0.49 | 0.66 | 0.65 | Upgrade
|
| PE Ratio | - | - | - | - | 15.65 | - | Upgrade
|
| PS Ratio | 0.66 | 0.42 | 0.57 | 0.56 | 0.57 | 0.81 | Upgrade
|
| PB Ratio | 0.90 | 0.57 | 0.70 | 0.52 | 0.64 | 0.66 | Upgrade
|
| P/TBV Ratio | 0.99 | 0.63 | 0.79 | 0.58 | 0.74 | 0.81 | Upgrade
|
| P/FCF Ratio | - | - | 17.71 | 5.04 | - | - | Upgrade
|
| P/OCF Ratio | 13.01 | 8.33 | 4.08 | 4.72 | - | - | Upgrade
|
| EV/Sales Ratio | 0.27 | 0.05 | 0.18 | 0.06 | 0.19 | 0.26 | Upgrade
|
| EV/EBITDA Ratio | 12.73 | 25.24 | - | - | 2.71 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 8.26 | - | Upgrade
|
| EV/FCF Ratio | -163.27 | - | 5.75 | 0.56 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.05 | 0.07 | 0.08 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 0.70 | 0.70 | - | - | 0.81 | - | Upgrade
|
| Debt / FCF Ratio | - | - | 1.33 | 0.65 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.53 | -0.53 | -0.53 | -0.43 | -0.32 | -0.42 | Upgrade
|
| Net Debt / EBITDA Ratio | -187.41 | -187.41 | 3.71 | 9.49 | -4.15 | 17.83 | Upgrade
|
| Net Debt / FCF Ratio | 235.60 | 235.60 | -13.44 | -4.19 | 5.36 | 4.40 | Upgrade
|
| Asset Turnover | 1.00 | 1.00 | 0.84 | 0.66 | 0.82 | 0.60 | Upgrade
|
| Inventory Turnover | 2.28 | 2.28 | 2.08 | 1.22 | 2.06 | 1.72 | Upgrade
|
| Quick Ratio | 2.27 | 2.27 | 1.99 | 2.50 | 2.40 | 2.25 | Upgrade
|
| Current Ratio | 3.33 | 3.33 | 2.78 | 3.80 | 3.39 | 2.99 | Upgrade
|
| Return on Equity (ROE) | -0.59% | -0.59% | -15.87% | -9.95% | 4.14% | -5.30% | Upgrade
|
| Return on Assets (ROA) | -3.03% | -3.03% | -8.67% | -4.61% | 1.15% | -3.35% | Upgrade
|
| Return on Invested Capital (ROIC) | -12.97% | -13.89% | -35.57% | -15.59% | 4.01% | -14.96% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.50% | -6.50% | -19.80% | -9.90% | 2.40% | -6.70% | Upgrade
|
| Earnings Yield | -0.66% | -1.03% | -24.72% | -20.28% | 6.39% | -8.10% | Upgrade
|
| FCF Yield | -0.25% | -0.39% | 5.65% | 19.84% | -9.26% | -14.25% | Upgrade
|
| Buyback Yield / Dilution | 2.61% | 2.61% | 4.44% | 3.55% | -1.18% | 1.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.